Related Experiment Video
Updated: Nov 3, 2025
28:13
Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
Published on: February 26, 2013
33.6K
Hypertension and atrial fibrillation: Closing a virtuous circle
Ying X Gue1, Gregory Y H Lip1,2
1Liverpool Centre for Cardiovascular Science, University of Liverpool and Liverpool Heart & Chest Hospital, Liverpool, United Kingdom.
Plos Medicine
|June 1, 2021
Summary
This study examines blood pressure lowering treatments for patients diagnosed with atrial fibrillation. It highlights the importance of tailored treatment strategies for managing this common cardiovascular condition.
Area of Science:
- Cardiology
- Pharmacology
Background:
- Atrial fibrillation is a common arrhythmia associated with increased risk of stroke.
- Blood pressure management is crucial in patients with atrial fibrillation to reduce cardiovascular events.
Purpose of the Study:
- To review and discuss the efficacy and safety of blood pressure lowering treatments in patients with atrial fibrillation.
- To provide insights into optimal therapeutic strategies for this patient population.
Main Methods:
- Review of current clinical guidelines and landmark studies.
- Discussion of pharmacological and non-pharmacological interventions for blood pressure control.
Main Results:
- Evidence suggests that achieving target blood pressure levels is beneficial in reducing stroke risk and other cardiovascular complications in atrial fibrillation.
- Individualized treatment approaches are necessary, considering patient-specific factors and comorbidities.
Conclusions:
- Effective blood pressure management is a cornerstone of comprehensive care for patients with atrial fibrillation.
- Further research may refine treatment algorithms for optimal outcomes.
More Related Videos
Related Concept Videos
01:29Hypertension II: Pathophysiology
274
Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
274
01:18Hypertension and Regulation of Blood Pressure
3.4K
Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
3.4K
01:28Hypertension I: Introduction
258
Hypertension is a widespread, long-term medical condition where blood pressure in the arteries remains elevated. It is characterized by systolic blood pressure readings of 130 mm Hg or above or diastolic blood pressure (DBP) readings of 80 mm Hg or higher. Unmanaged hypertension poses significant health risks, making the distinction between primary (or essential) hypertension and secondary hypertension crucial, as their management and implications vary.Primary HypertensionPrimary hypertension,...
258
01:30Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
1.9K
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
1.9K
01:29Heart Failure II: Pathophysiology
138
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
138
01:30Hypertension III: Clinical Manifestations and Diagnostic Studies
166
Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
166